Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Veterinary and Comparative Oncology|August 14, 2012
Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapyS Bavcar, D J ArgyleVeterinary Pathology|March 12, 2003
Telomerase: a potential diagnostic and therapeutic tool in canine oncologyD J Argyle, L NasirThe Journal of Small Animal Practice|March 5, 2002
Feline hyperthyroidism: advances towards novel molecular therapeuticsL Blackwood, D J ArgyleVeterinary and Comparative Oncology|September 17, 2009
Evaluation of the gene for inducible nitric oxide synthase as a radiosensitizer under hypoxic and oxic conditionsM Turek, M Padilla, D J ArgyleDomestic Animal Endocrinology|July 5, 2001
Characterization of the feline thyroglobulin promoterL Blackwood, D E Onions, D J ArgyleVeterinary Immunology and Immunopathology|March 5, 2011
CD44 is associated with proliferation, rather than a specific cancer stem cell population, in cultured canine cancer cellsT M Blacking, M Waterfall, D J ArgyleCancer Letters|May 18, 2000
Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasiaL Nasir, H Krasner, D J Argyle, et al.Veterinary and Comparative Oncology|April 22, 2009
Evaluation of telomerase-targeted therapies in canine cancer cell linesD J Argyle, T McKevitt, E Gault, et al.Veterinary and Comparative Oncology|June 13, 2018
Antibiotic prophylaxis in veterinary cancer chemotherapy: A review and recommendationsJ L Bisson, D J Argyle, S A ArgylePageof 7